Detalhe da pesquisa
1.
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis.
J Crohns Colitis
; 2024 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310565
2.
An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up.
J Drugs Dermatol
; 11(3): 300-12, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22395580
3.
Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn's Disease and 2 Years in Ulcerative Colitis.
Crohns Colitis 360
; 4(3): otac025, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36777422
4.
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.
Inflamm Bowel Dis
; 27(7): 994-1007, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32964215
5.
Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study.
J Dermatolog Treat
; 31(2): 152-159, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30887876
6.
Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants.
J Clin Pharmacol
; 49(6): 643-9, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19398602
7.
Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.
Drug Saf
; 42(6): 809, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012051
8.
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.
Drug Saf
; 42(6): 751-768, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739254
9.
A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years.
Arch Ophthalmol
; 123(9): 1177-86, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16157797